Phil Skolnick

Insider Reports History

Entity
Individual
Location
C/O Dov Pharmaceutical, Inc., 433 Hackensack Avenue, Hackensack, NJ
Signature
/s/ Phil Skolnick
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phil Skolnick:

Stock Role Class Num Shares Value Price $ Report Date Ownership
OPIANT PHARMACEUTICALS, INC. Chief Scientific Officer Common Stock 0 $20.00 Mar 2, 2023 Direct
OPIANT PHARMACEUTICALS, INC. Chief Scientific Officer Stock Option (right to buy) 0 $10.00 Mar 2, 2023 Direct

Insider Reports Filed by Phil Skolnick

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OPNT OPIANT PHARMACEUTICALS, INC. Mar 2, 2023 8 -$471K 4 Mar 3, 2023 Chief Scientific Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 27, 2023 1 -$9.72K 4 Jan 31, 2023 Chief Scientific Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 9, 2023 1 -$7.45K 4 Jan 9, 2023 Chief Scientific Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 5, 2023 1 -$28.7K 4 Jan 5, 2023 Chief Scientific Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jul 14, 2022 1 -$7.43K 4 Jul 15, 2022 Chief Scientific Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jun 27, 2022 1 $0 4 Jun 29, 2022 Chief Scientific Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 27, 2022 1 -$39.8K 4 Jan 27, 2022 Chief Scientific Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 10, 2022 1 -$11.7K 4 Jan 12, 2022 Chief Scientific Officer
OPNT OPIANT PHARMACEUTICALS, INC. Jan 4, 2022 1 $0 4 Jan 5, 2022 Chief Scientific Officer